Patrick Jamieson

Patrick is SVP of operations at Automata, bringing more than 15 years of experience scaling technology and biotech businesses. He has owned global P&Ls, led operational turnarounds, enterprise-wide transformations, guided companies through major fundraises and strategic transactions. Most recently Chief Operating Officer Alloy Therapeutics Antibody Discovery business, he previously held senior operating, strategy and corporate development roles at Ginkgo Bioworks, Motional, Aptiv, GlaxoSmithKline and Thermo Fisher Scientific. Patrick holds a BS in Economics-Finance from Bentley University, is a graduate of MIT's xPRO COO Program and has served on the boards of Otonomo, Affectiva and KRONO-SAFE.